Stifel Nicolaus & Co’s AbbVie ABBV Stock Holding History

Stifel Nicolaus & Co’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	$13.6M	Buy	305,113 +1,083	+0.4%	+$48K	0.23%	114
2013 Q2	$12.6M	Buy	+304,030	New	+$13.3M	0.23%	118

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Stifel Nicolaus & Co's ABBV Position: Q3 2013 in Review

Stifel Nicolaus & Co increased its AbbVie (ABBV) stake by 0.36% in Q3 2013, buying an estimated $48K and bringing the position to 305,113 shares worth $13.6M. The position accounts for 0.23% of the portfolio, ranked #114.

Stifel Nicolaus & Co first reported a position in ABBV in Q2 2013 and has held it in 2 quarters since. 1,297 funds tracked by Wall St. Rank hold ABBV as of Q3 2013.

Stifel Nicolaus & Co held 305,113 shares of AbbVie worth $13.6M as of Q3 2013.
Stifel Nicolaus & Co bought 1,083 AbbVie shares in Q3 2013, an estimated $48K.
AbbVie made up 0.23% of Stifel Nicolaus & Co's portfolio in Q3 2013, its #114 holding.
Stifel Nicolaus & Co first reported a position in AbbVie in Q2 2013 and has held it in 2 quarters since.
1,297 funds tracked by Wall St. Rank held AbbVie as of Q3 2013.

Based on Stifel Nicolaus & Co's 13F filing for Q3 2013, filed 13 Nov 2013.